Literature DB >> 11266195

Case-control study of nonfatal myocardial infarction in relation to selected foods in Japanese men and women.

S Sasazuki1.   

Abstract

Most studies of diet and coronary heart disease (CHD) have focused on constituents rather than on whole foods. The present study examined the relationship of selected foods to nonfatal acute myocardial infarction (AMI) in Japan, with special reference to vegetables, fruits, fish, and tofu. A total of 660 cases with their first episode of AMI aged 40-79 years living in Fukuoka City or adjacent areas and 1,277 controls matched for age, sex, and residence were surveyed on lifestyle, including dietary factors. Participation rates were 87% of cases and 52% of controls. Consumption frequencies of 19 food/beverages items and daily amounts of 4 items were ascertained by interview. The final analysis was done with 632 cases and 1,214 controls. Although consumption of vegetables showed no clear association with the risk of AMI, fruit consumption appeared to reduce the risk of AMI in both men and women. The results also suggested that fish consumption was related to a decreased risk of AMI in men, although the trend was not statistically significant. In women only, tofu consumption was inversely related to the risk of AMI; relative risks for eating tofu <2, 2-3, and 4+ times per week were 1.0, 0.8, and 0.5, respectively, after adjustment for non-dietary factors (p for trend = 0.01). Further adjustment for consumption of fruit, fish and tofu did not alter the findings generally. The findings suggest that, in women at least, tofu consumption may be protective against the risk of AMI. Further studies are needed to corroborate the relationship of consumption of fish and fruit to AMI risk in Japanese men and women.

Entities:  

Mesh:

Year:  2001        PMID: 11266195     DOI: 10.1253/jcj.65.200

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  8 in total

Review 1.  The Mediterranean diet, its components, and cardiovascular disease.

Authors:  R Jay Widmer; Andreas J Flammer; Lilach O Lerman; Amir Lerman
Journal:  Am J Med       Date:  2014-10-15       Impact factor: 4.965

Review 2.  Intake of fish and long-chain n-3 polyunsaturated fatty acids and risk of diseases in a Japanese population: a narrative review.

Authors:  Mitsumasa Umesawa; Kazumasa Yamagishi; Hiroyasu Iso
Journal:  Eur J Clin Nutr       Date:  2020-09-16       Impact factor: 4.016

3.  Safety and adherence of Umezu polyphenols in the Japanese plum (Prunus mume) in a 12-week double-blind randomized placebo-controlled pilot trial to evaluate antihypertensive effects.

Authors:  Shigeki Takemura; Kouichi Yoshimasu; Jin Fukumoto; Kanae Mure; Nobuhiro Nishio; Kunihiro Kishida; Fumiko Yano; Takahiko Mitani; Tatsuya Takeshita; Kazuhisa Miyashita
Journal:  Environ Health Prev Med       Date:  2014-09-13       Impact factor: 3.674

4.  Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial.

Authors:  Chesney K Richter; Ann C Skulas-Ray; Jennifer A Fleming; Christina J Link; Ratna Mukherjea; Elaine S Krul; Penny M Kris-Etherton
Journal:  Br J Nutr       Date:  2017-05       Impact factor: 3.718

Review 5.  The role of soy in vegetarian diets.

Authors:  Mark Messina; Virginia Messina
Journal:  Nutrients       Date:  2010-08-06       Impact factor: 5.717

Review 6.  Egg Consumption and Human Cardio-Metabolic Health in People with and without Diabetes.

Authors:  Nicholas R Fuller; Amanda Sainsbury; Ian D Caterson; Tania P Markovic
Journal:  Nutrients       Date:  2015-09-03       Impact factor: 5.717

Review 7.  Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature.

Authors:  Mark Messina
Journal:  Nutrients       Date:  2016-11-24       Impact factor: 5.717

8.  Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study.

Authors:  M C Houston; B Cooil; B J Olafsson; P Raggi
Journal:  Evid Based Complement Alternat Med       Date:  2007-12       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.